IGC Pharma, Inc.

Biotechnology • Healthcare • Potomac, MD, United States • IGC (ASE)

IGC Pharma, Inc., a clinical stage pharmaceutical company, develops treatments for Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's. Its pre-clinical stage product candidate includes TGR-63, IGC-M3, and LMP to treat Alzheimer's disease; IGC-1C for the treatment of metabolic disorders and Alzheimer's disease; and IGC-1A to treat metabolic disorders. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland.

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

IGC Pharma (IGC) spotlights Alzheimer's cannabinoid trial amid Schedule III talks - Stock Titan

Stock Titan • Dec 15

IGC Pharma (IGC): Ascendiant Capital Raises Price Target to $4.7 - GuruFocus

GuruFocus • Dec 9

IGC Pharma Adjusts Fiscal Year-End to December 31 - TipRanks

TipRanks • Jan 2

All You Need to Know About IGC Pharma, Inc. (IGC) Rating Upgrade to Strong Buy - Nasdaq

Nasdaq • Oct 24

IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q2 results. We believe more positive clinical data and progress in 2025/26 to be strong catalysts for stock. Raising P/T to $4.75." - Finviz

Finviz • Dec 10

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has IGC Pharma, Inc. had layoffs?

No layoff events have been recorded for IGC Pharma, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does IGC Pharma, Inc. have?

IGC Pharma, Inc. has approximately 70 employees.

What industry is IGC Pharma, Inc. in?

IGC Pharma, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is IGC Pharma, Inc. a publicly traded company?

Yes, IGC Pharma, Inc. is publicly traded under the ticker symbol IGC on the ASE. The company has a market capitalization of approximately $0.03 billion.

Where is IGC Pharma, Inc. headquartered?

IGC Pharma, Inc. is headquartered in Potomac, MD, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.